Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to prospectively compare the physiologic response of patients who receive either intravenous gadoxetic acid (Eovist) or intravenous gadobenate dimeglumine (MultiHance).

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Michigan

Criteria

Inclusion Criteria:

• Patients 18 years old and older

• Patients scheduled for MRI examination at the University of Michigan hospital

• Patients receiving either MultiHance or Eovist contrast agents during their clinical MRI examination

Exclusion Criteria:

• Patients under 18 years of age

• Patients who will not receive MultiHance or Eovist as part of their clinical MRI examination